RxDoctor Payments DataLook up a doctor →

Christopher Scheiner, MD

Neurology · Dayton, OHNPI 1487864773

Payments from drug & device makers

$454,025in general payments, 2019–2025

Across 811 payments — averaging $559.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$246K
  • CSL Behring$155K
  • Amgen$19K
  • Argenx US, Inc.$15K
  • Johnson & Johnson$11K
  • UCB, Inc.$4K
  • plus $3K from 45 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)219$246,233
CSL Behring328$154,716
Amgen(2 entities)22$18,948
Argenx US, Inc.52$15,376
Johnson & Johnson(2 entities)17$11,201
UCB, Inc.29$4,148
Janssen Scientific Affairs, LLC4$322
Biogen11$283
AbbVie(2 entities)12$188
Sanofi7$179
Akcea Therapeutics, Inc.1$156
Alnylam Pharmaceuticals Inc.7$152
Biohaven Pharmaceuticals, Inc.6$145
Genentech USA, Inc.5$115
TG Therapeutics, Inc.5$108
Neurelis, Inc.4$94
Catalyst Pharmaceuticals, Inc.5$93
E.r. Squibb & Sons, L.L.C.5$93
Pfizer4$90
Neurocrine Biosciences, Inc.4$89
Novartis3$86
Bristol Myers Squibb4$80
Banner Life Sciences, LLC3$68
Takeda Pharmaceuticals U.S.A., Inc.3$68
EMD Serono, Inc.3$68
Hospira, Inc.3$67
Grifols USA, LLC3$67
Octapharma USA, Inc.3$66
Tanabe Pharma America, Inc.3$65
Biohaven Pharmaceutical Holding Company Ltd.3$65
SK Life Science, Inc.3$58
Eisai Inc.3$56
Sunovion Pharmaceuticals Inc.4$52
Mallinckrodt Hospital Products Inc.2$42
Lundbeck LLC2$36
Neuropace, Inc.1$33
Sanofi-aventis U.S. LLC2$30
Cycle Pharmaceuticals Inc2$29
Vanda Pharmaceuticals Inc.2$28
ANI Pharmaceuticals, Inc.1$26
Greenwich Biosciences, Inc.1$26
GE HealthCare1$24
Immedica Pharma US, Inc.1$23
Otsuka America Pharmaceutical, Inc.1$22
Lilly USA, LLC1$20
Averitas Pharma Inc.1$19
Scilex Pharmaceuticals Inc.1$18
Teva Pharmaceuticals USA, Inc.1$16
Kyowa Kirin, Inc.1$14
Almatica Pharma LLC1$14
Sumitomo Pharma America, Inc.1$11

How this compares

$454,025 in reported general payments places this provider in the 90th percentile of 702 neurology providers in Ohio.

See all neurology providers in Ohio →

Medicare billing

Part B allowed, 2024
$43,055
Medicare patients
169
Services billed
475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Dayton

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →